Table 1.
Comp. | Type | R | R1 | R2 | EC50 (μM) |
CC50 (μM) |
SIp | SIa | IC50 (μM) |
|
---|---|---|---|---|---|---|---|---|---|---|
L. infantum promastigotes | L. infantum amastigotes | Human HepG2 | Leishmanial TopIB |
|||||||
1 | NQ | I | Cl | 22.8 ± 0.6 | >100 | 50.1 ± 2.4 | 2.2 | <0.50 | 23.5 ± 1.3 | |
2 | NQ | I | Br | Br | 11.7 ± 0.1 | 90.0 ± 4.3 | 14.7 ± 0.8 | 1.3 | 0.16 | 13.5 ± 0.6 |
3 | NQ | I | Br | >100 | 12.8 ± 1.5 | 160 ± 12 | <1.6 | 12 | >100 | |
4 | NQ | I | H | 0.57 ± 0.04 | 7.74 ± 0.07 | 10.8 ± 0.8 | 18.9 | 1.4 | 50.1 ± 5.0 | |
5 | NQ | II | Cl | H | 18.8 ± 0.6 | >100 | 104 ± 8 | 5.5 | <1.0 | >100 |
6 |
NQ |
II |
Cl |
|
11.4 ± 0.5 |
28.8 ± 1.4 |
131 ± 6 |
11.5 |
4.5 |
73.5 ± 3.4 |
7 | NHQ | II | H | H | 7.19 ± 0.17 | 7.18 ± 0.28 | 4.33 ± 0.28 | 0.6 | 0.60 | >100 |
8 | NHQ | II | CH3 | H | 12.7 ± 0.3 | 5.71 ± 0.59 | 28.0 ± 1.2 | 2.2 | 4.9 | >100 |
9 | NHQ | II | OCH3 | H | 15.3 ± 0.3 | 50.3 ± 0.3 | 28.6 ± 1.3 | 1.9 | 0.57 | >100 |
10 | NHQ (5,8-dihydro) | II | CH3 | H | 10.9 ± 0.5 | 3.61 ± 0.69 | > 200 | >18.3 | > 55 | >100 |
11 |
NHQ |
|
H |
H |
6.19 ± 0.03 |
17.8 ± 1.2 |
7.66 ± 0.26 |
1.2 |
0.43 |
>100 |
12 | 1,4-AQ | – | H | H | 1.20 ± 0.08 | 23.0 ± 2.1 | 13.4 ± 1.3 | 11.2 | 0.58 | 10.7 ± 2.2 |
13 | 1,4-AQ | – | OCH3 | H | 7.56 ± 0.14 | 14.2 ± 2.5 | 29.7 ± 1.3 | 3.9 | 2.1 | 91.8 ± 8.2 |
14 | 1,4-AQ | – | OEt | H | 16.1 ± 0.8 | 14.8 ± 1.9 | 199 ± 14 | 12.4 | 13 | >100 |
15 | 1,4-AQ | – | NHEt | H | 19.9 ± 1.7 | 33.8 ± 5.2 | 149 ± 9 | 7.5 | 4.4 | >100 |
16 | 1,4-AQ | – | NHEt | Cl | 12.5 ± 0.0 | 66.6 ± 3.3 | > 200 | 16.0 | >3.0 | >100 |
17 |
1,4-AQ |
– |
|
H |
13.5 ± 0.4 |
16.3 ± 2.1 |
> 200 |
14.8 |
> 12 |
>100 |
18 | 1,4-AHQ (9,10-dihydro) | – | H | H | 15.9 ± 1.1 | 1.22 ± 0.01 | 37.0 ± 2.1 | 2.3 | 30 | >100 |
19 | 1,4-AHQ | – | H | H | 3.3 ± 0.1 | 2.64 ± 0.01 | 5.94 ± 0.31 | 1.8 | 2.3 | >100 |
20 |
1,4-AHQ |
– |
OCH3 |
H |
16.6 ± 0.4 |
19.3 ± 1.6 |
54.6 ± 5.3 |
3.3 |
2.8 |
>100 |
21 | 9,10-AQ | II | H | H | 18.2 ± 1.1 | 21.5 ± 1.1 | 57.8 ± 1.7 | 3.2 | 2.7 | 57.9 ± 4.1 |
22 | 9,10-AQ | H | H | 57.5 ± 0.2 | 44.8 ± 1.6 | 147 ± 11 | 2.5 | 3.3 | >100 | |
23 | 9,10-AQ (4a,9a-dihydro) | II | H | H | 69.6 ± 8.4 | >100 | 82.9 ± 5.3 | 1.2 | >0.83 | >100 |
24 | 9,10-AQ (4a,9a-dihydro) | H | H | 85.4 ± 2.5 | 21.6 ± 2.4 | >200 | 2.3 | >9.3 | >100 | |
25 |
BAcQ |
|
39.0 ± 4.3 |
24.9 ± 0.30 |
124 ± 8 |
3.2 |
5.0 |
41.4 ± 7.4 |
||
MTF | 5.9 ± 1.4 | 2.40 ± 0.21 | 50.4 ± 4.3 | 8.5 | 21 | nt | ||||
AMB | 0.77 ± 0.15 | 0.32 ± 0.05 | nt | un | un | nt |
SIp: Selectivity Index for promastigotes (CC50 HepG2/EC50 promastigotes); SIa: Selectivity Index for amastigotes (CC50 HepG2/EC50 amastigotes); MTF: Miltefosine; AMB: Amphotericin B deoxycholate; nt: not tested; un: undefined. Significant values (EC50: ≤10 μM, SI: ≥ 10, and CC50 ≥ 100 μM) are bolded for comparison purposes.